A new study has revealed that the drug called pembrolizumab, sold under the brand name Keytruda, not only kept head and neck ...

Hundreds of thousands of people with advanced head and neck cancer could live longer without their cancer returning thanks to ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall survival (OS) analysis of the Phase III INAVO120 study. These data showed ...

When Fatigue Isn’t Just Tiredness In the outpatient clinic, it’s not uncommon to meet young women who’ve been living with ...